Protalix BioTherapeutics, Inc.PLXNYSE
LOADING
|||
Price to Sales: Discounted Valuation
Trending higher, below historical average, structural decline.
Left:
||||
Price-to-sales ratio
Latest
2.55
↓ 91% below average
Average (9y)
28.57
Historical baseline
Range
High:221.86
Low:0.89
CAGR
-39.1%
Structural decline
| Period | Value | Change |
|---|---|---|
| 2024 | 2.55 | +39.2% |
| 2023 | 1.83 | +31.6% |
| 2022 | 1.39 | +45.6% |
| 2021 | 0.96 | -43.1% |
| 2020 | 1.68 | +89.0% |
| 2019 | 0.89 | -33.4% |
| 2018 | 1.34 | -67.5% |
| 2017 | 4.11 | -91.6% |
| 2016 | 49.05 | -77.9% |
| 2015 | 221.86 | - |